Sweden· SE-19940629000013
Bezalip Retard 400 mg Depottablett
A medicinal product containing bezafibrate, registered in Sweden by Actavis Group PTC ehf..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Bezafibrate
- Manufacturer
- Actavis Group PTC ehf.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19940629000013
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bezafibrate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBezafibrate 400mg modified-release tabletsDE Pharmaceuticals
- NetherlandsBezalip Retard 400 mg, tabletten met gereguleerde afgifteEuro Registratie Collectief B.V.
- FinlandBezafibrat GenericsGenerics (UK) Limited
- NorwayBezalip RetardAurobindo Pharma
- SpainDIFATEROL RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADALaboratorios Bial S.A.
- CanadaBEZALIP SRALLERGAN INC
- FranceBEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongéeARROW GENERIQUES
- BelgiumEulitop 400 mgAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Bezalip Retard, Bezastad
- Belgium · Cedur, Eulitop
- Cyprus · Lacromid, Zafibral
- Germany · Bezafibrat Al, Bezafibrat Retard Al
- Spain · Eulitop, Eulitop Retard
- Finland · Bezalip
- France · Befizal, Befizal L.P.
- United Kingdom (Northern Ireland) · Bezafibrate, Bezafibrate Noumed Life Sciences
- Hungary · Bezalip
- Italy · Bezalip
- Luxembourg · Cedur, Eulitop
- Netherlands · Bezafibrate Aurobindo
- Portugal · Bezalip, Bezalip Retard
- Romania · Bezafibrat Arena
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f0e6b52-4e39-41f5-b7f8-4dee9eb0cf3f GET /v1/drugs/8f0e6b52-4e39-41f5-b7f8-4dee9eb0cf3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19940629000013",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19940629000013",
"product_doc_link": "https://docetp.mpa.se/LMF/Bezalip%20Retard%20prolonged-release%20tablet%20SmPC_09001bee807a118b.pdf"
}See everything about bezafibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.